Insmed Q1 2024 GAAP EPS $(1.06) Beats $(1.23) Estimate, Sales $75.500M Miss $77.758M Estimate
Insmed Q1 2024 GAAP EPS $(1.06) Beats $(1.23) Estimate, Sales $75.500M Miss $77.758M Estimate
Insmed 2024年第一季度GAAP每股收益美元（1.06）超过预期（1.23），销售额为7,550亿美元，低于7,7758万美元的预期
Insmed (NASDAQ:INSM) reported quarterly losses of $(1.06) per share which beat the analyst consensus estimate of $(1.23) by 13.82 percent. This is a 9.4 percent increase over losses of $(1.17) per share from the same period last year. The company reported quarterly sales of $75.500 million which missed the analyst consensus estimate of $77.758 million by 2.90 percent. This is a 15.77 percent increase over sales of $65.214 million the same period last year.
Insmed（纳斯达克股票代码：INSM）公布的季度亏损为每股1.06美元，比分析师普遍预期的1.23美元（1.23美元）高出13.82％。这比去年同期每股亏损1.17美元（1.17美元）增长了9.4％。该公司公布的季度销售额为7,550亿美元，比分析师普遍预期的7,775.8万美元低2.90％。这比去年同期的6,5214万美元的销售额增长了15.77％。